Drug recall: Morphine Sulfate 30 mg, 60 mg Extended Release Tablets recalled due to this reason

Risk Statement: Patients prescribed the 30 mg dose who receive the 60 mg dose could be at risk for overdose and death.

587
Drug recall
Drug recall

Last Updated on October 11, 2024 by The Health Master

Burbank, California, Bryant Ranch Prepack Inc. is voluntarily recalling one lot of Morphine Sulfate 30 mg Extended-Release tablets (comprised of 10 bottles), and one lot of Morphine Sulfate 60 mg Extended-Release tablets (comprised of 10 bottles) to the consumer level listed in the table below.

The products have been found to have incorrect labeling where:

  • Bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets
  • Bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Risk Statement: Patients prescribed the 30 mg dose who receive the 60 mg dose could be at risk for overdose and death.

Patients prescribed the 60 mg dose who receive the 30 mg dose may experience withdrawal and untreated pain if the dose given is too low.

To date, Bryant Ranch Prepack Inc. has not received any reports of adverse events related to this recall.

ProductStrengthQuantity per bottleNDCLotExpiration
Morphine Sulfate Extended-Release Tablets30 mg10063629-1088-0117964211/30/2023
60 mg10063629-1089-0117964308/31/2023

Morphine Sulfate Extended-Release tablets are used to manage severe pain. The 30 mg tablets are round, purple-colored, film-coated tablets debossed with “RD” and “71” on one side and plain on the other side.

The 60 mg tablets are round, light orange-colored, film-coated tablets debossed with “RD” and “72” on one side and plain on the other side.

Bryant Ranch Prepack is notifying its distributors and customers by email, phone, and letter, and is arranging for the return of all recalled products.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Drug recall: Over 6 lakh bottles of Blood Pressure treatment tablets recalled

Drug recall: 2.1 million doses of medicine recalled due to this reason

Drug recall: Over 10,000 bottles of generic Anti-depression Drug recalled

Drug recall: Quinapril HCl recalled due to N-Nitroso-Quinapril Content

Drug recall: Pfizer recalls some batches of Blood Pressure drug due to this reason

Drug recall: Insulin Glargine recalled due to this reason

NPPA extends price regulation on LMO, Oxygen Concentrators and Medicinal Gas

2 Doctors suspended for favouring Pharma Company

USFDA issues one observation to Glenmark for Aurangabad Facility

NPPA fixes retail prices of 84 drug formulations

9th edition of IP released containing 3,152 Monographs

USFDA gives final approval for Lacosamide Injection

USFDA clears watch-like wearable BP monitoring technology

QR code could curb circulation of fake, spurious and substandard medicines

These 4 countries accept Indian Pharmacopoeia (IP) as book of standard

Drug Alert: NSQ Drugs Lists

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news